Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Open-Label Extension for Neuropathic Pain After SCI
NCT00141375Phase 3Completed
- Sponsor
- Pfizer
- Start
- Aug 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pregabalin in neuropathic pain, sponsored by Pfizer. Primary endpoints: Safety and Efficacy. Started Aug 2002; status: completed.
02
Drugs
pregabalin
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT00141375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141375.